New diabetes clinical trial: Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA)

Published on: April 17, 2019 at 07:00PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: SGLT-2i;   Drug: DPP-4i
Sponsor:   University of Campania "Luigi Vanvitelli"
Recruiting